VENOCONSTRICTOR RESPONSES TO DIHYDROERGOCRISTINE AND DIHYDROERGOTAMINE - EVIDENCE FOR THE INVOLVEMENT OF 5-HT1 LIKE RECEPTORS

被引：11

作者：

MULLERSCHWEINITZER, E

机构：

[1] Preclinical Research, Sandoz Pharma AG, Basel

来源：

CARDIOVASCULAR DRUGS AND THERAPY | 1990年 / 4卷 / 06期

关键词：

VENOCONSTRICTION; DIHYDROERGOTAMINE; DIHYDROERGOCRISTINE; 5-HT1-LIKE RECEPTORS; METHIOTHEPIN; YOHIMBINE;

D O I：

10.1007/BF02026491

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Dihydroergocristine (DHEC) and dihydroergotamine (DHE) were investigated on canine saphenous veins in vivo and on canine saphenous veins and basilar arteries in vitro. Following local IV infusion in vivo, the venoconstrictor response to DHEC was about 30% weaker than that produced by DHE. When administered orally, however, both ergot alkaloids elicited similar venoconstrictor effects. In vitro maximal contractile responses to DHEC and DHE of basilar arteries were only 20-30% of those produced by 5-HT, whereas in saphenous veins both DHEC and DHE elicited similar maximal effects as those observed with 5-HT. In saphenous veins, methiothepin antagonized venoconstrictor responses to 5-HT, DHEC, and DHE within the same concentration range, being significantly less potent when tested against noradrenaline. The reverse was true for yohimbine, which was significantly more potent against noradrenaline than against 5-HT, DHEC, and DHE. It is suggested that the venoconstrictor responses to both DHEC and DHE are mediated through 5-HT1-like receptors.

引用

页码：1455 / 1460

页数：6

共 25 条

[1]

Clark B.J., Chu D., Aellig W.H., Actions on the heart and circulation, pp. 231-420, (1978)

[2]

Muller-Schweinitzer E., Alpha-adrenoceptors, 5-hydroxytryptamine receptors and the action of dihydroergotamine in human venous preparations, Naunyn Schmiedeberg's Arch Pharmacol, 327, pp. 299-303, (1984)

[3]

Muller-Schweinitzer E., Rosenthaler J., Dihydroergotamine: Pharmacokinetics, pharmacodynamics, and mechanism of venoconstrictor action in beagle dogs, Journal of Cardiovascular Pharmacology, 9, pp. 686-693, (1987)

[4]

Schardt F., Polzien P., Hochdrucktherapie mit Briserin: Welche Rolle spielt die Dihydroergocristin-Komponente?, Med Klin, 76, pp. 746-752, (1981)

[5]

Schardt F., Die orthostatische Dysregulation als Begleitphänomen der antihypertensiven Therapie: Die verschiedenen Präparateprofile, Hochdrucktherapie im Alter mit Hydergin: Neue Gesichtspunkte Nüruberger Expertengespräche 1982, pp. 57-69, (1983)

[6]

Muller-Schweinitzer E., The recording of venous compliance in the conscious dog. A method for the assessment of venoconstrictor agents, J. Pharmacol Methods, 12, pp. 53-58, (1984)

[7]

Muller-Schweinitzer E., Tapparelli C., Pharmacological studies on frozen stored canine saphenous veins and basilar arteries, Naunyn Schmiedeberg's Arch Pharmacol, 332, pp. 74-78, (1986)

[8]

Muller-Schweinitzer E., Tapparelli C., Cryopreservation of isolated blood vessels for pharmacological studies: Experiments on canine and human veins, Neuronal messengers in vascular function, pp. 105-110, (1987)

[9]

Ebeigbe A.B., Muller-Schweinitzer E., Vogel A., Effects of calcium channel blockade in canine saphenous veins after storage at −190°C, Br J Pharmacol, 94, pp. 381-388, (1988)

[10]

Muller-Schweinitzer E., Cryopreservation: A useful technique for storing tissues for pharmacological investigations, TIPS, 9, pp. 221-223, (1988)

← 1 2 3 →